Univar Inc (NYSE:UNVR) target price upped to $25.00, issued a research note today by Zacks Investment Research
- Updated: October 12, 2016
Yesterday Univar Inc (NYSE:UNVR) traded -0.65% lower at $21.39. Univar Inc’s 50-day average is $20.74 and its two hundred day average is $19.00. With the last close up 12.10% relative to the two hundred day average, compared with the Standard & Poor's 500 Index which has decreased -0.01% over the same time period. 76,092 shares of the stock traded hands, down from an average trading volume of 639,803
In a report issued 10/12/2016 Zacks Investment Research increased the stock price target of Univar Inc (NYSE:UNVR) to $25.00 reporting a potential upside of 0.17%.
Previously on 9/9/2016, Jefferies Group reported about Univar Inc (NYSE:UNVR) raised the target price from $0.00 to $26.00 that indicated a possible upside of 0.27%.
See Chart Below
Univar Inc has a 52 week low of $10.65 and a 52 week high of $22.76 with a PE ratio of 46.51 The company’s market cap is currently $0.
Also covering Univar Inc's price target, a total of 7 analysts have issued a research note on the company. The average stock price target is $19.71 with 2 firms rating the stock a strong buy, two equity analysts rating the company a buy, 5 brokerages rating the company a hold, zero brokers rating the stock a underperform, and finally 0 brokerages rating the stock a sell.
Brief Synopsis On Univar Inc (NYSE:UNVR)
Univar Inc. is a distributor of commodity and specialty chemicals. The Company's segments include Univar USA (USA); Univar Canada (Canada); Univar Europe, the Middle East and Africa (EMEA), and Rest of World. The Rest of World segment includes developing businesses in Latin America, including Brazil and Mexico, and the Asia-Pacific region. Its USA segment offers commodity and specialty chemicals to manufacturing and industrial production sectors in the United States. Its Canadian operations are divided into approximately two regions: Eastern Canada, where it focuses on customer end markets, including cleaning and sanitization, chemical manufacturing, personal care and pharmaceutical, and Western Canada, where it focuses on forestry, chemical manufacturing, mining, and oil and gas markets, such as midstream gas and oil sands processing, as well as refining. Its EMEA segment caters to pharmaceutical products and ingredients, food, coating and adhesives, and personal care industries.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.